Ranolazine
NDC 27241-125 · Ajanta Pharma USA Inc.
Generic nameRanolazine
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)RANOLAZINE
Strength500 mg/1
Pharmacologic classAnti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing categoryANDA
Packages
27241-125-02 — 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-02)
27241-125-05 — 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-05)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0615-8611 — Ranolazine, 0904-7506 — Ranolazine, 13668-759 — Ranolazine, 13668-760 — Ranolazine, 27241-126 — Ranolazine, 29300-296 — Ranolazine, 29300-297 — Ranolazine, 31722-668 — Ranolazine, 31722-669 — Ranolazine, 42291-773 — RANOLAZINE, 42291-774 — RANOLAZINE, 47335-625 — Ranolazine, 50228-423 — RANOLAZINE, 50228-424 — RANOLAZINE, 50268-722 — Ranolazine, 50268-723 — Ranolazine, 59651-009 — Ranolazine, 59651-010 — Ranolazine, 60290-055 — Ranolazine, 60290-056 — Ranolazine, +34 more